Ultragenyx Pharmaceutical, Inc. (RARE)
16.07
-0.20
(-1.23%)
USD |
NASDAQ |
Nov 13, 16:00
16.07
0.00 (0.00%)
After-Hours: 19:59
Ultragenyx Pharmaceutical Shareholders Equity (Quarterly) : -376.00M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -376.00M |
| June 30, 2026 | -291.00M |
| March 31, 2026 | -236.00M |
| December 31, 2025 | -80.00M |
| September 30, 2025 | 9.159M |
| June 30, 2025 | 151.29M |
| March 31, 2025 | 144.25M |
| December 31, 2024 | 255.30M |
| September 30, 2024 | 346.83M |
| June 30, 2024 | 432.42M |
| March 31, 2024 | 140.26M |
| December 31, 2023 | 275.41M |
| September 30, 2023 | 31.71M |
| June 30, 2023 | 129.03M |
| March 31, 2023 | 220.48M |
| December 31, 2022 | 352.49M |
| September 30, 2022 | 468.83M |
| June 30, 2022 | 678.07M |
| March 31, 2022 | 796.42M |
| December 31, 2021 | 922.56M |
| September 30, 2021 | 933.67M |
| June 30, 2021 | 972.17M |
| March 31, 2021 | 1.055B |
| December 31, 2020 | 1.154B |
| September 30, 2020 | 666.19M |
| Date | Value |
|---|---|
| June 30, 2020 | 695.59M |
| March 31, 2020 | 609.15M |
| December 31, 2019 | 653.76M |
| September 30, 2019 | 727.26M |
| June 30, 2019 | 819.79M |
| March 31, 2019 | 886.73M |
| December 31, 2018 | 608.91M |
| September 30, 2018 | 662.60M |
| June 30, 2018 | 703.97M |
| March 31, 2018 | 723.66M |
| December 31, 2017 | 383.45M |
| September 30, 2017 | 365.56M |
| June 30, 2017 | 429.45M |
| March 31, 2017 | 488.48M |
| December 31, 2016 | 473.97M |
| September 30, 2016 | 455.89M |
| June 30, 2016 | 443.90M |
| March 31, 2016 | 489.82M |
| December 31, 2015 | 531.09M |
| September 30, 2015 | 576.76M |
| June 30, 2015 | 319.28M |
| March 31, 2015 | 341.12M |
| December 31, 2014 | 184.94M |
| September 30, 2014 | 199.33M |
| June 30, 2014 | 153.08M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | 393.64M |
| AbbVie, Inc. | -4.583B |
| Krystal Biotech, Inc. | 1.436B |
| BridgeBio Pharma, Inc. | -1.662B |
| Alnylam Pharmaceuticals, Inc. | 3.604B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.187B |
| Total Liabilities (Quarterly) | 1.556B |
| Debt to Equity Ratio | -3.154 |
| Current Ratio | 1.398 |
| Net Debt Paydown Yield | -3.96% |